[CBAY] YoY Quarter Result on 31-Dec-2023 [#Q4]

Stock
[CBAY] CymaBay Therapeutics, Inc.
Announcement Date
28-Feb-2024
Financial Year
2023
Quarter
31-Dec-2023 [#Q4]
Profit Trend
QoQ- -23.67%
YoY- -15.18%
Quarter Report
CBAY's Result
CBAY's Financial Summary
View:
Show?
Quarter Result
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
Revenue 57 0 0 0 0 0 5,207 -52.86%
PBT -41,902 -26,633 -26,543 -15,751 -29,413 -19,449 -5,043 42.29%
Tax 0 9,748 5,139 -123 -150 1,106 -543 -
NP -41,902 -36,381 -26,543 -15,751 -29,413 -19,449 -5,043 42.29%
Tax Rate - - - - - - - -
Total Cost 41,959 36,381 26,543 15,751 29,413 19,449 10,250 26.46%
Ratio Analysis
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
NP Margin -73,512.28 0.00 0.00 0.00 0.00 0.00 -96.85 201.87%
Per Share
31/12/23 31/12/22 31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 CAGR
EPS -0.37 -0.41 -0.38 -0.23 -0.43 -0.31 -0.09 26.55%
EPS Diluted -0.37 -0.41 -0.38 -0.23 -0.43 -0.31 -0.09 26.55%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.